APOGEM CAPITAL LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 49 filers reported holding PROQR THRAPEUTICS N V in Q4 2022. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
APOGEM CAPITAL LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2022$93,000
-4.1%
124,424
-0.7%
0.09%
+5.7%
Q2 2022$97,000
+142.5%
125,273
+185.4%
0.09%
+225.9%
Q1 2022$40,000
-81.4%
43,900
+63.3%
0.03%
-80.9%
Q4 2021$215,000
+17.5%
26,875
+23.1%
0.14%
+21.6%
Q3 2021$183,000
-15.3%
21,830
-31.9%
0.12%
-15.9%
Q2 2021$216,000
-5.7%
32,037
-7.6%
0.14%
-11.0%
Q1 2021$229,000
+241.8%
34,654
+118.6%
0.16%
+244.4%
Q4 2020$67,00015,8550.04%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders